speb/financial-data huggingface dataset:
MGX income_statement (annual, 2023-12-31) — Research And Development: 94403000.00
MGX balance_sheet (annual, 2023-12-31) — Retained Earnings: -144944000.00
MGX cash_flow (annual, 2023-12-31) — Sale Of Investment: 263644000.00
MGX income_statement (annual, 2023-12-31) — Selling General And Administration: 28845000.00
MGX balance_sheet (annual, 2023-12-31) — Share Issued: 37527695.00
MGX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 6922000.00
MGX balance_sheet (annual, 2023-12-31) — Stockholders Equity: -135584000.00
MGX balance_sheet (annual, 2023-12-31) — Tangible Book Value: -135584000.00
MGX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 602700.00
MGX income_statement (annual, 2023-12-31) — Tax Provision: 8027000.00
MGX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
MGX balance_sheet (annual, 2023-12-31) — Total Assets: 364842000.00
MGX balance_sheet (annual, 2023-12-31) — Total Capitalization: -135584000.00
MGX balance_sheet (annual, 2023-12-31) — Total Debt: 48229000.00
MGX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -135584000.00
MGX income_statement (annual, 2023-12-31) — Total Expenses: 123248000.00
MGX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 500426000.00
MGX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 86569000.00
MGX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 431565000.00
MGX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -78492000.00
MGX balance_sheet (annual, 2023-12-31) — Total Partnership Capital: -135584000.00
MGX balance_sheet (annual, 2023-12-31) — Total Tax Payable: 3266000.00
MGX income_statement (annual, 2023-12-31) — Total Unusual Items: 2870000.00
MGX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 2870000.00
MGX cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -2870000.00
MGX balance_sheet (annual, 2023-12-31) — Working Capital: 209412000.00
MGX income_statement (quarterly, 2024-09-30) — Basic Average Shares: 36766309.00
MGX income_statement (quarterly, 2024-09-30) — Basic EPS: -0.51
MGX cash_flow (quarterly, 2024-09-30) — Change In Income Tax Payable: 0.00
MGX cash_flow (quarterly, 2024-09-30) — Change In Tax Payable: 0.00
MGX income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 36766309.00
MGX income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.51
MGX income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: -2055000.00
MGX balance_sheet (quarterly, 2024-09-30) — Income Tax Payable: 0.00
MGX cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 0.00
MGX balance_sheet (quarterly, 2024-09-30) — Preferred Securities Outside Stock Equity: 0.00
MGX cash_flow (quarterly, 2024-09-30) — Preferred Stock Issuance: 0.00
MGX cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
MGX cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
MGX balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 0.00
MGX income_statement (quarterly, 2024-09-30) — Total Unusual Items: -2055000.00
MGX income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -2055000.00
MGX cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: 2055000.00
MGX income_statement (annual, 2024-12-31) — +Operating Expense: 141196000.00
MGX income_statement (annual, 2024-12-31) — +Total Revenue: 52295000.00
MGX balance_sheet (annual, 2024-12-31) — Accounts Payable: 533000.00
MGX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1257000.00
MGX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -11269000.00
MGX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -11269000.00
MGX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 457146000.00
MGX cash_flow (annual, 2024-12-31) — Amortization Of Securities: -6169000.00
MGX cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1042000.00
MGX cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 752000.00
MGX income_statement (annual, 2024-12-31) — Basic Average Shares: 33027889.00
MGX income_statement (annual, 2024-12-31) — Basic EPS: -2.36
MGX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 145851000.00
MGX cash_flow (annual, 2024-12-31) — Capital Expenditure: -3114000.00
MGX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 45778000.00
MGX balance_sheet (annual, 2024-12-31) — Capital Stock: 4000.00
MGX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 27386000.00
MGX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 248307000.00
MGX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 84013000.00
MGX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -88157000.00
MGX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -109073000.00
MGX cash_flow (annual, 2024-12-31) — Change In Account Payable: -1106000.00
MGX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -893000.00
MGX cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -3266000.00
MGX cash_flow (quarterly, 2024-12-31) — Change In Income Tax Payable: 0.00
MGX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -6470000.00
MGX cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -46804000.00
MGX cash_flow (annual, 2024-12-31) — Change In Payable: -4372000.00
MGX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -5265000.00
MGX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -2323000.00
MGX cash_flow (annual, 2024-12-31) — Change In Receivables: 1194000.00
MGX cash_flow (annual, 2024-12-31) — Change In Tax Payable: -3266000.00
MGX cash_flow (quarterly, 2024-12-31) — Change In Tax Payable: 0.00
MGX cash_flow (annual, 2024-12-31) — Change In Working Capital: -59668000.00
MGX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 1194000.00
MGX cash_flow (annual, 2024-12-31) — Changes In Cash: -113217000.00
MGX balance_sheet (annual, 2024-12-31) — Common Stock: 4000.00
MGX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 234857000.00
MGX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 84013000.00
MGX cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
MGX balance_sheet (annual, 2024-12-31) — Construction In Progress: 143000.00
MGX balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 143000.00
MGX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 3076000.00
MGX balance_sheet (annual, 2024-12-31) — Current Assets: 257960000.00
MGX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 5592000.00
MGX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 5592000.00
MGX balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 22762000.00
MGX balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 22762000.00
MGX balance_sheet (annual, 2024-12-31) — Current Liabilities: 37309000.00
MGX cash_flow (annual, 2024-12-31) — Depreciation: 5407000.00
MGX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 5407000.00
MGX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 5407000.00
MGX income_statement (annual, 2024-12-31) — Diluted Average Shares: 33027889.00
MGX income_statement (annual, 2024-12-31) — Diluted EPS: -2.36
MGX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -78058000.00
MGX income_statement (annual, 2024-12-31) — EBIT: -88901000.00
MGX income_statement (annual, 2024-12-31) — EBITDA: -83494000.00
MGX cash_flow (annual, 2024-12-31) — End Cash Position: 32634000.00
MGX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 84013000.00
MGX cash_flow (annual, 2024-12-31) — Free Cash Flow: -112187000.00
MGX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -9185000.00
MGX income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -7130000.00
MGX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 709000.00
MGX income_statement (annual, 2024-12-31) — General And Administrative Expense: 32017000.00
MGX balance_sheet (annual, 2024-12-31) — Gross PPE: 68926000.00
MGX cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 3505000.00
MGX balance_sheet (annual, 2024-12-31) — Income Tax Payable: 0.00
MGX balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 0.00
MGX income_statement (annual, 2024-12-31) — Interest Income: 14722000.00
MGX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 14722000.00
MGX balance_sheet (annual, 2024-12-31) — Invested Capital: 234857000.00
MGX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -88157000.00
MGX balance_sheet (annual, 2024-12-31) — Investments And Advances: 3447000.00
MGX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 84013000.00
MGX cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
MGX balance_sheet (annual, 2024-12-31) — Leases: 4375000.00
MGX balance_sheet (quarterly, 2024-12-31) — Leases: 4375000.00
MGX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 40186000.00
MGX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 40186000.00
MGX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1411000.00
MGX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1411000.00
MGX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 84013000.00
MGX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
MGX income_statement (annual, 2024-12-31) — Net Income: -78058000.00
MGX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -78058000.00
MGX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -78058000.00
MGX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -78058000.00
MGX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -78058000.00
MGX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -78058000.00
MGX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -78058000.00
MGX income_statement (annual, 2024-12-31) — Net Interest Income: 14722000.00
MGX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -85043000.00
MGX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 14722000.00
MGX balance_sheet (annual, 2024-12-31) — Net PPE: 57657000.00
MGX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -3114000.00
MGX cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
MGX cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00
MGX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 234857000.00
MGX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 10237000.00
MGX balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 10237000.00
MGX income_statement (annual, 2024-12-31) — Normalized EBITDA: -74309000.00
MGX income_statement (annual, 2024-12-31) — Normalized Income: -69479210.00
MGX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -109073000.00
MGX income_statement (annual, 2024-12-31) — Operating Income: -88901000.00
MGX income_statement (annual, 2024-12-31) — Operating Revenue: 52295000.00
MGX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 37418470.00
MGX balance_sheet (annual, 2024-12-31) — Other Current Assets: 8396000.00
MGX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 709000.00
MGX income_statement (annual, 2024-12-31) — Other Gand A: 32017000.00
MGX income_statement (annual, 2024-12-31) — Other Income Expense: -9392000.00
MGX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2984000.00
MGX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 5535000.00
MGX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 2010000.00
MGX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -207000.00
MGX balance_sheet (annual, 2024-12-31) — Other Properties: 62997000.00
MGX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 220921000.00
MGX balance_sheet (annual, 2024-12-31) — Payables: 533000.00
MGX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 3609000.00
MGX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5346000.00
MGX balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
MGX balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
MGX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
MGX cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
MGX cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 0.00
MGX income_statement (annual, 2024-12-31) — Pretax Income: -83571000.00
MGX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
MGX balance_sheet (annual, 2024-12-31) — Properties: 0.00
MGX balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MGX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -306420000.00
MGX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -3114000.00
MGX balance_sheet (annual, 2024-12-31) — Receivables: 1257000.00
MGX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 5407000.00
MGX income_statement (annual, 2024-12-31) — Research And Development: 109179000.00
MGX balance_sheet (annual, 2024-12-31) — Retained Earnings: -223002000.00
MGX cash_flow (annual, 2024-12-31) — Sale Of Investment: 221377000.00
MGX cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
MGX income_statement (annual, 2024-12-31) — Selling General And Administration: 32017000.00
MGX balance_sheet (annual, 2024-12-31) — Share Issued: 37418470.00
MGX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 16204000.00
MGX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 234857000.00
MGX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 234857000.00
MGX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -606210.00
MGX income_statement (annual, 2024-12-31) — Tax Provision: -5513000.00
MGX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.07
MGX balance_sheet (annual, 2024-12-31) — Total Assets: 324599000.00
MGX balance_sheet (annual, 2024-12-31) — Total Capitalization: 234857000.00
MGX balance_sheet (annual, 2024-12-31) — Total Debt: 45778000.00
MGX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 234857000.00
MGX income_statement (annual, 2024-12-31) — Total Expenses: 141196000.00
MGX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 89742000.00
MGX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 66639000.00
MGX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 52433000.00
MGX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -88901000.00
MGX balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
MGX balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 0.00
MGX income_statement (annual, 2024-12-31) — Total Unusual Items: -9185000.00
MGX income_statement (quarterly, 2024-12-31) — Total Unusual Items: -7130000.00
MGX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -9185000.00
MGX income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -7130000.00
MGX cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 9185000.00
MGX cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 7130000.00
MGX balance_sheet (annual, 2024-12-31) — Working Capital: 220651000.00
MGX income_statement (quarterly, 2025-03-31) — +Operating Expense: 31947000.00
MGX income_statement (quarterly, 2025-03-31) — +Total Revenue: 4127000.00
MGX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2670000.00
MGX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1012000.00
MGX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 460074000.00
MGX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -1007000.00
MGX cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
MGX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 37019027.00
MGX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.68
MGX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 32634000.00
MGX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -288000.00
MGX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 44437000.00
MGX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4000.00
MGX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 29195000.00
MGX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 225970000.00
MGX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -77000.00
MGX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 24728000.00
MGX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -22842000.00
MGX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2210000.00
MGX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -2648000.00
MGX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1273000.00
MGX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -3049000.00
MGX cash_flow (quarterly, 2025-03-31) — Change In Payable: 2210000.00
MGX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -438000.00
MGX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 2237000.00
MGX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 245000.00
MGX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2278000.00
MGX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 245000.00
MGX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1809000.00
MGX balance_sheet (quarterly, 2025-03-31) — Common Stock: 4000.00
MGX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 212658000.00
MGX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
MGX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2712000.00
MGX balance_sheet (quarterly, 2025-03-31) — Current Assets: 233195000.00
MGX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 5603000.00
MGX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 5603000.00
MGX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 25500000.00
MGX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 25500000.00
MGX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 39893000.00
MGX cash_flow (quarterly, 2025-03-31) — Depreciation: 1358000.00
MGX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1358000.00
MGX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1358000.00
MGX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 37019027.00
MGX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.68
MGX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -25039000.00
MGX income_statement (quarterly, 2025-03-31) — EBIT: -27820000.00
MGX income_statement (quarterly, 2025-03-31) — EBITDA: -26462000.00
MGX cash_flow (quarterly, 2025-03-31) — End Cash Position: 34443000.00
MGX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -77000.00
MGX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -23130000.00
MGX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 621000.00
MGX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 6805000.00
MGX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 55195000.00
MGX income_statement (quarterly, 2025-03-31) — Interest Income: 2887000.00
MGX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2887000.00
MGX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 212658000.00
MGX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 24728000.00
MGX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 3447000.00
MGX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
MGX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 38834000.00
MGX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 38834000.00
MGX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
MGX income_statement (quarterly, 2025-03-31) — Net Income: -25039000.00
MGX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -25039000.00
MGX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -25039000.00
MGX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -25039000.00
MGX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -25039000.00
MGX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -25039000.00
MGX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -25039000.00
MGX income_statement (quarterly, 2025-03-31) — Net Interest Income: 2887000.00
MGX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 25016000.00
MGX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 2887000.00
MGX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -77000.00
MGX balance_sheet (quarterly, 2025-03-31) — Net PPE: 55195000.00
MGX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -288000.00
MGX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 212658000.00
MGX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4372000.00
MGX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 4372000.00
MGX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -26462000.00
MGX income_statement (quarterly, 2025-03-31) — Normalized Income: -25039000.00
MGX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -22842000.00
MGX income_statement (quarterly, 2025-03-31) — Operating Income: -27820000.00
MGX income_statement (quarterly, 2025-03-31) — Operating Revenue: 4127000.00
MGX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 37382478.00
MGX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 6213000.00
MGX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 621000.00
MGX income_statement (quarterly, 2025-03-31) — Other Gand A: 6805000.00
MGX income_statement (quarterly, 2025-03-31) — Other Income Expense: -8000.00
MGX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1196000.00
MGX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 6029000.00
MGX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 2109000.00
MGX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -8000.00
MGX balance_sheet (quarterly, 2025-03-31) — Other Properties: 55195000.00
MGX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 196775000.00
MGX balance_sheet (quarterly, 2025-03-31) — Payables: 2670000.00
MGX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 5382000.00
MGX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 3408000.00
MGX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
MGX income_statement (quarterly, 2025-03-31) — Pretax Income: -24941000.00
MGX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -22287000.00
MGX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -288000.00
MGX balance_sheet (quarterly, 2025-03-31) — Receivables: 1012000.00
MGX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1358000.00
MGX income_statement (quarterly, 2025-03-31) — Research And Development: 25142000.00
MGX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -248041000.00
MGX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 47303000.00
MGX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 6805000.00
MGX balance_sheet (quarterly, 2025-03-31) — Share Issued: 37382478.00
MGX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2928000.00
MGX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 212658000.00
MGX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 212658000.00
MGX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MGX income_statement (quarterly, 2025-03-31) — Tax Provision: 98000.00
MGX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
MGX balance_sheet (quarterly, 2025-03-31) — Total Assets: 297866000.00
MGX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 212658000.00
MGX balance_sheet (quarterly, 2025-03-31) — Total Debt: 44437000.00
MGX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 212658000.00
MGX income_statement (quarterly, 2025-03-31) — Total Expenses: 31947000.00
MGX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 85208000.00
MGX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 64671000.00
MGX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 45315000.00
MGX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -27820000.00
MGX balance_sheet (quarterly, 2025-03-31) — Working Capital: 193302000.00
MGX income_statement (quarterly, 2025-06-30) — +Operating Expense: 29500000.00
MGX income_statement (quarterly, 2025-06-30) — +Total Revenue: 8513000.00
MGX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2891000.00
MGX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 873000.00
MGX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 463404000.00
MGX cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -818000.00
MGX cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 181000.00
MGX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 37156979.00
MGX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.54
MGX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 34443000.00
MGX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -127000.00
MGX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 42990000.00
MGX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 4000.00
MGX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 26850000.00
MGX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 204993000.00
MGX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -166000.00
MGX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 19072000.00
MGX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -21251000.00
MGX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 74000.00
MGX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 172000.00
MGX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1402000.00
MGX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -7368000.00
MGX cash_flow (quarterly, 2025-06-30) — Change In Payable: 74000.00
MGX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 246000.00
MGX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 450000.00
MGX cash_flow (quarterly, 2025-06-30) — Change In Receivables: 139000.00
MGX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -7935000.00
MGX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 139000.00
MGX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2345000.00
MGX balance_sheet (quarterly, 2025-06-30) — Common Stock: 4000.00
MGX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 195831000.00
MGX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
MGX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1864000.00
MGX balance_sheet (quarterly, 2025-06-30) — Current Assets: 211681000.00
MGX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 5508000.00
MGX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 5508000.00
MGX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 18942000.00
MGX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 18942000.00
MGX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 33265000.00
MGX cash_flow (quarterly, 2025-06-30) — Depreciation: 1335000.00
MGX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1335000.00
MGX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1335000.00
MGX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 37156979.00
MGX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.54
MGX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -19908000.00
MGX income_statement (quarterly, 2025-06-30) — EBIT: -20987000.00
MGX income_statement (quarterly, 2025-06-30) — EBITDA: -19652000.00
MGX cash_flow (quarterly, 2025-06-30) — End Cash Position: 32098000.00
MGX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -166000.00
MGX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -21378000.00
MGX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -1292000.00
MGX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 372000.00
MGX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 6993000.00
MGX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 52396000.00
MGX income_statement (quarterly, 2025-06-30) — Interest Income: 2485000.00
MGX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2485000.00
MGX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 195831000.00
MGX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 19072000.00
MGX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2154000.00
MGX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
MGX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 37482000.00
MGX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 37482000.00
MGX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
MGX income_statement (quarterly, 2025-06-30) — Net Income: -19908000.00
MGX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -19908000.00
MGX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -19908000.00
MGX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -19908000.00
MGX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -19908000.00
MGX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -19908000.00
MGX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -19908000.00
MGX income_statement (quarterly, 2025-06-30) — Net Interest Income: 2485000.00
MGX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 19162000.00
MGX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 2485000.00
MGX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -275000.00
MGX balance_sheet (quarterly, 2025-06-30) — Net PPE: 52396000.00
MGX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -90000.00
MGX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 195831000.00
MGX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3553000.00
MGX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 3553000.00
MGX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -18360000.00
MGX income_statement (quarterly, 2025-06-30) — Normalized Income: -18887320.00
MGX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -21251000.00
MGX income_statement (quarterly, 2025-06-30) — Operating Income: -20987000.00
MGX income_statement (quarterly, 2025-06-30) — Operating Revenue: 8513000.00
MGX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 37533136.00
MGX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 5815000.00
MGX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 372000.00
MGX income_statement (quarterly, 2025-06-30) — Other Gand A: 6993000.00
MGX income_statement (quarterly, 2025-06-30) — Other Income Expense: -1362000.00
MGX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1381000.00
MGX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 6053000.00
MGX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 2153000.00
MGX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -70000.00
MGX balance_sheet (quarterly, 2025-06-30) — Other Properties: 52396000.00
MGX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 178143000.00
MGX balance_sheet (quarterly, 2025-06-30) — Payables: 2891000.00
MGX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4755000.00
MGX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 4060000.00
MGX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
MGX income_statement (quarterly, 2025-06-30) — Pretax Income: -19864000.00
MGX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -18509000.00
MGX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -127000.00
MGX balance_sheet (quarterly, 2025-06-30) — Receivables: 873000.00
MGX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1335000.00
MGX income_statement (quarterly, 2025-06-30) — Research And Development: 22507000.00
MGX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -267949000.00
MGX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 37671000.00
MGX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 6993000.00
MGX balance_sheet (quarterly, 2025-06-30) — Share Issued: 37533136.00
MGX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3221000.00
MGX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 195831000.00
MGX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 195831000.00
MGX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -271320.00
MGX income_statement (quarterly, 2025-06-30) — Tax Provision: 44000.00
MGX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
MGX balance_sheet (quarterly, 2025-06-30) — Total Assets: 272284000.00
MGX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 195831000.00
MGX balance_sheet (quarterly, 2025-06-30) — Total Debt: 42990000.00
MGX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 195831000.00
MGX income_statement (quarterly, 2025-06-30) — Total Expenses: 29500000.00
MGX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 76453000.00
MGX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 60603000.00
MGX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 43188000.00
MGX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -20987000.00
MGX income_statement (quarterly, 2025-06-30) — Total Unusual Items: -1292000.00
MGX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -1292000.00
MGX balance_sheet (quarterly, 2025-06-30) — Working Capital: 178416000.00
MGX income_statement (quarterly, 2025-09-30) — +Operating Expense: 31498000.00
MGX income_statement (quarterly, 2025-09-30) — +Total Revenue: 8659000.00
MGX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1215000.00
MGX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 960000.00
MGX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 466414000.00
MGX cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -705000.00
MGX cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
MGX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 37349449.00
MGX income_statement (quarterly, 2025-09-30) — Basic EPS: -0.55
MGX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 32098000.00
MGX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -74000.00
MGX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 41663000.00
MGX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 4000.00
MGX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 32773000.00
MGX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 184114000.00
MGX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -187000.00
MGX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 27363000.00
MGX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -21253000.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1576000.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 4023000.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 0.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1562000.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -7574000.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Payable: -1576000.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2447000.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 1140000.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -87000.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 0.00
MGX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -5636000.00
MGX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -87000.00
MGX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 5923000.00
MGX balance_sheet (quarterly, 2025-09-30) — Common Stock: 4000.00
MGX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 178447000.00
MGX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
MGX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 4784000.00
MGX balance_sheet (quarterly, 2025-09-30) — Current Assets: 189820000.00
MGX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 5571000.00
MGX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5571000.00
MGX balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 12900000.00
MGX balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 12900000.00
MGX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 29583000.00
MGX cash_flow (quarterly, 2025-09-30) — Depreciation: 1324000.00
MGX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1324000.00
MGX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1324000.00
MGX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 37349449.00
MGX income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.55
MGX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -20393000.00
MGX income_statement (quarterly, 2025-09-30) — EBIT: -22839000.00
MGX income_statement (quarterly, 2025-09-30) — EBITDA: -21515000.00
MGX cash_flow (quarterly, 2025-09-30) — End Cash Position: 38021000.00
MGX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -187000.00
MGX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -21327000.00
MGX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 371000.00
MGX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 6215000.00
MGX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 49906000.00
MGX income_statement (quarterly, 2025-09-30) — Interest Income: 2214000.00
MGX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2214000.00
MGX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 178447000.00
MGX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 27363000.00
MGX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2154000.00
MGX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
MGX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 36092000.00
MGX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 36092000.00
MGX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
MGX income_statement (quarterly, 2025-09-30) — Net Income: -20393000.00
MGX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -20393000.00
MGX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -20393000.00
MGX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -20393000.00
MGX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -20393000.00
MGX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -20393000.00
MGX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -20393000.00
MGX income_statement (quarterly, 2025-09-30) — Net Interest Income: 2214000.00
MGX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 27437000.00
MGX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 2214000.00
MGX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -187000.00
MGX balance_sheet (quarterly, 2025-09-30) — Net PPE: 49906000.00
MGX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -74000.00
MGX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 178447000.00
MGX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1896000.00
MGX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 1896000.00
MGX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -21515000.00
MGX income_statement (quarterly, 2025-09-30) — Normalized Income: -20393000.00
MGX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -21253000.00
MGX income_statement (quarterly, 2025-09-30) — Operating Income: -22839000.00
MGX income_statement (quarterly, 2025-09-30) — Operating Revenue: 8659000.00
MGX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 37546751.00
MGX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 4746000.00
MGX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 371000.00
MGX income_statement (quarterly, 2025-09-30) — Other Gand A: 6215000.00
MGX income_statement (quarterly, 2025-09-30) — Other Income Expense: -2000.00
MGX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1147000.00
MGX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 6057000.00
MGX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1919000.00
MGX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -2000.00
MGX balance_sheet (quarterly, 2025-09-30) — Other Properties: 49906000.00
MGX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 151341000.00
MGX balance_sheet (quarterly, 2025-09-30) — Payables: 1215000.00
MGX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 5999000.00
MGX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 5113000.00
MGX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
MGX income_statement (quarterly, 2025-09-30) — Pretax Income: -20627000.00
MGX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
MGX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -6063000.00
MGX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -74000.00
MGX balance_sheet (quarterly, 2025-09-30) — Receivables: 960000.00
MGX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1324000.00
MGX income_statement (quarterly, 2025-09-30) — Research And Development: 25283000.00
MGX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -288342000.00
MGX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 33500000.00
MGX cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
MGX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 6215000.00
MGX balance_sheet (quarterly, 2025-09-30) — Share Issued: 37546751.00
MGX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3010000.00
MGX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 178447000.00
MGX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 178447000.00
MGX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MGX income_statement (quarterly, 2025-09-30) — Tax Provision: -234000.00
MGX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.01
MGX balance_sheet (quarterly, 2025-09-30) — Total Assets: 247937000.00
MGX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 178447000.00
MGX balance_sheet (quarterly, 2025-09-30) — Total Debt: 41663000.00
MGX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 178447000.00
MGX income_statement (quarterly, 2025-09-30) — Total Expenses: 31498000.00
MGX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 69490000.00
MGX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 58117000.00
MGX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 39907000.00
MGX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -22839000.00
MGX cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
MGX balance_sheet (quarterly, 2025-09-30) — Working Capital: 160237000.00
MGX income_statement (annual, 2025-12-31) — +Operating Expense: 121223000.00
MGX income_statement (quarterly, 2025-12-31) — +Operating Expense: 28278000.00
MGX income_statement (annual, 2025-12-31) — +Total Revenue: 25210000.00
MGX income_statement (quarterly, 2025-12-31) — +Total Revenue: 3911000.00
MGX balance_sheet (annual, 2025-12-31) — Accounts Payable: 1489000.00
MGX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1489000.00
MGX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 305000.00
MGX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 305000.00
MGX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -15961000.00
MGX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -15961000.00
MGX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 469202000.00
MGX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 469202000.00
MGX cash_flow (annual, 2025-12-31) — Amortization Of Securities: -3000000.00
MGX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -470000.00
MGX cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 502000.00
MGX cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 321000.00
MGX income_statement (annual, 2025-12-31) — Basic Average Shares: 37251050.00
MGX income_statement (annual, 2025-12-31) — Basic EPS: -2.36
MGX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 32634000.00
MGX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 38021000.00
MGX cash_flow (annual, 2025-12-31) — Capital Expenditure: -574000.00
MGX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -85000.00
MGX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 40657000.00
MGX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 40657000.00
MGX balance_sheet (annual, 2025-12-31) — Capital Stock: 4000.00
MGX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4000.00
MGX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 41722000.00
MGX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 41722000.00